The emerging biology of delusions

Psychological Medicine

Volumn 41, Issue 1, 2011, Pages 7-13

  Murray, G K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Learning; motivation; psychosis; reward; salience

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR;

BIOLOGICAL MODEL; BRAIN; DELUSION; EDITORIAL; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOSIS;

BRAIN; DELUSIONS; DOPAMINE; HUMANS; MODELS, NEUROLOGICAL; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE;

EID: 78650380352     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291710000413     Document Type: Review

References (67)

1. Aarsland D, Bronnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL (2007). Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. Journal of Neurology, Neurosurgery and Psychiatry 78, 36-42.
2. 2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences USA 97, 8104-8109.
3. Agid O, Kapur S, Arenovich T, Zipursky RB (2003). Delayed-onset hypothesis of antipsychotic action. A hypothesis tested and rejected. Archives of General Psychiatry 60, 1228-1235.
4. Agid O, Kapur S, Warrington L, Loebel A, Siu C (2008). Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders. Schizophrenia Research 102, 241-248.
5. Beninger RJ (1983). The role of dopamine in locomotor activity and learning. Brain Research 287, 173-196.
6. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D (1997). Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciences USA 94, 2569-2574.
7. Chouinard G, Miller R (1999a). A rating scale for psychotic symptoms (RSPS) part I: theoretical principles and subscale 1: perception symptoms (illusions and hallucinations). Schizophrenia Research 38, 101-122.
8. Chouinard G, Miller R (1999b). A rating scale for psychotic symptoms (RSPS): part II: subscale 2: distraction symptoms (catatonia and passivity experiences subscale 3: delusions and semi-structured interview (SSCI-RSPS). Schizophrenia Research 38, 123-150.
9. Coltheart M (2007). Cognitive neuropsychiatry and delusional belief. Quarterly Journal of Experimental Psychology 60, 1041-1062.
10. Corlett PR, Krystal JH, Taylor JR, Fletcher PC (2009). Why do delusions persist? Frontiers in Human Neuroscience 3, 12.
11. Corlett PR, Murray GK, Honey GD, Aitken MR, Shanks DR, Robbins TW, Bullmore ET, Dickinson A, Fletcher PC (2007). Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain 130, 2387-2400.
12. David AS (2006). A method for studies of madness. Cortex 42, 921-925.
13. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E (2008). The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. American Journal of Psychiatry 165, 1015-1023.
14. Feinberg I (1978). Efference copy and corollary discharge: implications for thinking and its disorders. Schizophrenia Bulletin 4, 636-640.
15. Fletcher PC, Frith CD (2009). Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nature Reviews Neuroscience 10, 48-58.
16. Frith CD (1992). The Cognitive Neuropsychology of Schizophrenia. Taylor and Francis: Hove, UK.
17. Garety PA, Bebbington P, Fowler D, Freeman D, Kuipers E (2007). Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. Psychological Medicine 37, 1377-1391.
18. Garety PA, Hemsley DR, Wessely S (1991). Reasoning in deluded schizophrenic and paranoid patients. Biases in performance on a probabilistic inference task. Journal of Nervous and Mental Disease 179, 194-201.
19. Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT (2008). Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biological Psychiatry 64, 774-781.
20. Goto Y, Otani S, Grace AA (2007). The Yin and Yang of dopamine release: a new perspective. Neuropharmacology 53, 583-587.
21. Grace AA, Floresco SB, Goto Y, Lodge DJ (2007). Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends in Neurosciences 30, 220-227.
22. Gray JA, Feldon J, Rawlins JNP, Smith AD (1991). The neuropsychology of schizophrenia. Behavior and Brain Sciences 14, 1-19.
23. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009). Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry 66, 13-20.
24. Jensen J, Willeit M, Zipursky RB, Savina I, Smith AJ, Menon M, Crawley AP, Kapur S (2008). The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology 33, 473-479.
25. Kapur S (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry 160, 13-23.
26. Kapur S, Arenovich T, Agid O, Zipursky R, Lindborg S, Jones B (2005). Evidence for onset of antipsychotic effects within the first 24 hours of treatment. American Journal of Psychiatry 162, 939-946.
27. Kegeles L, Frankle WG, Gil R, Talbot PS, Narendran R, Silfstein M, Huang Y, Hwang DR, Cangianio C, Cooper TB, Haber SN, Abi-Dargham A, Laruelle M (2007). Schizophrenia is associated with increased synaptic dopamine in associative rather than limbic striatum: implications for mechanism of action of antipsychotic drugs. Schizophrenia Bulletin 33, 294.
28. Kennedy N, Everitt B, Boydell J, Van Os J, Jones PB, Murray RM (2005). Incidence and distribution of first-episode mania by age: results from a 35-year study. Psychological Medicine 35, 855-863.
29. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences USA 93, 9235-9240.
30. Lewis DA, Hashimoto T, Morris HM (2008). Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotoxocity Research 14, 237-248.
31. Lisman JE, Grace AA (2005). The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 46, 703-713.
32. Lodge DJ, Grace AA (2006). The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31, 1356-1361.
33. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC (2000). Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. American Journal of Psychiatry 157, 708-714.
34. Makinen J, Miettunen J, Isohanni M, Koponen H (2008). Negative symptoms in schizophrenia: a review. Nordic Journal of Psychiatry 62, 334-341.
35. Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, du Montcel ST, Yelnik J, Chereau I, Arbus C, Raoul S, Aouizerate B, Damier P, Chabardes S, Czernecki V, Ardouin C, Krebs MO, Bardinet E, Chaynes P, Burbaud P, Cornu P, Derost P, Bougerol T, Bataille B, Mattei V, Dormont D, Devaux B, Verin M, Houeto JL, Pollak P, Benabid AL, Agid Y, Krack P, Millet B, Pelissolo A (2008). Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. New England Journal of Medicine 359, 2121-2134.
36. Mallet L, Schupbach M, N'Diaye K, Remy P, Bardinet E, Czernecki V, Welter ML, Pelissolo A, Ruberg M, Agid Y, Yelnik J (2007). Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proceedings of the National Academy of Sciences USA 104, 10661-10666.
37. Mathalon DH, Ford JM (2008). Corollary discharge dysfunction in schizophrenia: evidence for an elemental deficit. Clinical EEG Neuroscience 39, 82-86.
38. McGuire PK, Silbersweig DA, Wright I, Murray RM, David AS, Frackowiak RS, Frith CD (1995). Abnormal monitoring of inner speech: a physiological basis for auditory hallucinations. Lancet 346, 596-600.
39. McKenna PJ (1987). Pathology, phenomenology and the dopamine hypothesis of schizophrenia. British Journal of Psychiatry 151, 288-301.
40. Miller R (1976). Schizophrenic psychology, associative learning and the role of forebrain dopamine. Medical Hypotheses 2, 203-211.
41. Miller R (2008). A Neurodynamic Theory of Schizophrenia. Lulu: New Zealand.
42. Mizrahi R, Bagby RM, Zipursky RB, Kapur S (2005). How antipsychotics work: the patients' perspective. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29, 859-864.
43. Mizrahi R, Kiang M, Mamo DC, Arenovich T, Bagby RM, Zipursky RB, Kapur S (2006). The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders. Schizophrenia Research 88, 111-118.
44. Murray GK, Cheng F, Clark L, Barnett JH, Blackwell AD, Fletcher PC, Robbins TW, Bullmore ET, Jones PB (2008a). Reinforcement and reversal learning in first-episode psychosis. Schizophrenia Bulletin 34, 848-855.
45. Murray GK, Clark L, Corlett PR, Blackwell AD, Cools R, Jones PB, Robbins TW, Poustka L (2008b). Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry 8, 34.
46. Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, Jones PB, Bullmore ET, Robbins TW, Fletcher PC (2008c). Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Molecular Psychiatry 13, 239, 267-276.
47. Murray GK, Corlett PR, Fletcher PC (2010). The neural underpinnings of associative learning in health and psychosis: how can performance be preserved when brain responses are abnormal? Schizophrenia Bulletin. Published online: 12 February 2010. doi:10.1093/schbul/ sbq005.
48. Murray GK, Fletcher PC (2009). Can models of reinforcement learning help us to understand symtpoms of schizophrenia? In Handbook of Reward and Decision-Making (ed. J.-C. Dreher and L. Tremblay), pp. 251-269. Elsevier: Oxford.
49. Nestler EJ, Carlezon Jr. WA (2006). The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 59, 1151-1159.
50. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK (2004). Identification of separable cognitive factors in schizophrenia. Schizophrenia Research 72, 29-39.
51. Ohayon MM, Schatzberg AF (2002). Prevalence of depressive episodes with psychotic features in the general population. American Journal of Psychiatry 159, 1855-1861.
52. Owen GS, Cutting J, David AS (2007). Are people with schizophrenia more logical than healthy volunteers? British Journal of Psychiatry 191, 453-454.
53. Parsey RV, Oquendo MA, Zea-Ponce Y, Rodenhiser J, Kegeles LS, Pratap M, Cooper TB, Van Heertum R, Mann JJ, Laruelle M (2001). Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biological Psychiatry 50, 313-322.
54. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD (2006). Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442, 1042-1045.
55. Robbins TW, Everitt BJ (1996). Neurobehavioural mechanisms of reward and motivation. Current Opinion in Neurobiology 6, 228-236.
56. Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A (2008). Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology 196, 673-684.
57. Schlagenhauf F, Sterzer P, Schmack K, Ballmaier M, Rapp M, Wrase J, Juckel G, Gallinat J, Heinz A (2009). Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biological Psychiatry 65, 1032-1039.
58. Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T, Malaspina D, Small SA (2009). Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Archives of General Psychiatry 66, 938-946.
59. Schultz W, Dayan P, Montague PR (1997). A neural substrate of prediction and reward. Science 275, 1593-1599.
60. Shergill SS, Samson G, Bays PM, Frith CD, Wolpert DM (2005). Evidence for sensory prediction deficits in schizophrenia. American Journal of Psychiatry 162, 2384-2386.
61. Sommer IE, Daalman K, Rietkerk T, Diederen KM, Bakker S, Wijkstra J, Boks MP (2008). Healthy individuals with auditory verbal hallucinations; who are they? Psychiatric assessments of a selected sample of 103 subjects. Schizophrenia Bulletin. Published online: 9 October 2008. doi:10.1093/schbul/ sbn130.
62. Stein L, Wise CD (1971). Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 171, 1032-1036.
63. Toda M, Abi-Dargham A (2007). Dopamine hypothesis of schizophrenia: making sense of it all. Current Psychiatry Reports 9, 329-336.
64. van Os J (2003). Is there a continuum of psychotic experiences in the general population? Epidemiologia e Psichiatria Sociale 12, 242-252.
65. Waltz JA, Gold JM (2007). Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophrenia Research 93, 296-303.
66. Yung A, Phillips L, McGorry P (2004). Treating Schizophrenia in the Prodromal Phase. Martin Dunitz: Basingstoke, UK.
67. Ziauddeen H, Murray GK (2010). The relevance of reward pathways for schizophrenia. Current Opinion in Psychiatry 23, 91-96.